Atrial Fibrillation
📧 Sign up to get email alerts when something new happens for Atrial Fibrillation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-01Clinical Trial Update: D-Dimer-based Indication for Transesophageal Echocardiography to Exclude Left Atrial Thrombus Before Cardioversion of Non-anticoagulated Atrial Fibrillation: A Multicenter Belgian Study [Phase 4]
Phase 4 clinical trial update evaluating D-Dimer-based indication for transesophageal echocardiography to exclude left atrial thrombus prior…
-
CLINICAL_TRIALS trial_result · 2023-01-27Clinical Trial Update: Video-based Detection of Atrial Fibrillation [NA]
A completed clinical trial investigating video-based detection of atrial fibrillation; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-01-17Clinical Trial Update: The Safety and Efficacy Of Rivaroxaban and Ticagrelor for Patients With Atrial Fibrillation After Percutaneous Coronary Intervention [Phase 3]
A Phase 3 trial updating safety and efficacy of rivaroxaban plus ticagrelor in patients with atrial fibrillation after percutaneous coronary…
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Simplified Pulmonary Vein Isolation Using singLe Catheter and IntraCardiac Echocardiography [Phase 4]
Phase 4 trial update on simplified pulmonary vein isolation using a single catheter and intracardiac echocardiography for atrial fibrillatio…
-
CLINICAL_TRIALS trial_result · 2023-01-04Clinical Trial Update: Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion [Phase 4]
A Phase 4 clinical trial evaluates how different anti-thrombotic strategies affect the incidence of silent cerebral embolism after percutane…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-03Clinical Trial Update: Rivaroxaban Estimation With Warfarin in Atrial Fibrillation Patients With Coronary Stent Implantation Study (REWRAPS) [Phase 4]
Phase 4 trial evaluating rivaroxaban estimation with warfarin in atrial fibrillation patients with coronary stent implantation (REWRAPS).
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: mHealth Screening to Prevent Strokes [NA]
A completed clinical trial evaluating mHealth screening to prevent strokes in atrial fibrillation patients; results posted in 2022.
-
FDA approval · 2022-12-02FDA Approved: ESMOLOL HYDROCHLORIDE — Original Application (WG Critical Care, LLC)
FDA approved the original application for esmolol hydrochloride in saline (sodium chloride) solution, a generic injectable beta-blocker.
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: Performance of QDOT Micro™ Catheter With nGEN Generator for Patients With AFIB. [NA]
A completed clinical trial evaluated the performance of the QDOT Micro Catheter with the nGEN Generator in patients with atrial fibrillation…
-
FDA approval · 2022-11-28FDA Approved: DOFETILIDE — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for dofetilide filed by Bionpharma Inc. under an ANDA, approving a change to the approved product.
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Clinical Outcomes Between Anticoagulation and DAPT Therapy in AF Patients Successfully Undergoing LAAO [Phase 4]
Phase 4 trial update comparing anticoagulation versus dual antiplatelet therapy in AF patients post-LAAO to assess clinical outcomes.
-
CLINICAL_TRIALS trial_result · 2022-11-08Clinical Trial Update: Post-Ablation Pericarditis Reduction Study [Phase 2]
Phase 2 trial update on reducing post-ablation pericarditis in patients undergoing catheter ablation for atrial fibrillation; study complete…
-
CLINICAL_TRIALS trial_result · 2022-11-07Clinical Trial Update: Prevention of Silent Cerebral Thromboembolism by Oral Anticoagulation With Dabigatran After Pulmonary Vein Isolation for Atrial Fibrillation [Phase 4]
A Phase 4 trial investigated whether dabigatran oral anticoagulation after pulsed vein isolation reduces silent cerebral thromboembolism in …
-
FDA approval · 2022-11-02FDA Approved: LANOXIN — Supplemental Application (Covis Pharma US, Inc)
The FDA approved a supplemental application for LANOXIN (digoxin) submitted by Covis Pharma US, Inc. This approval covers the changes reques…
-
CLINICAL_TRIALS trial_result · 2022-11-01Clinical Trial Update: Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments [Phase 4]
Phase 4 trial update evaluating point-of-care randomisation systems for embedded comparative effectiveness trials of routine treatments.
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Study to Gather Information About the Proper Dosing of the Oral FXIa Inhibitor BAY 2433334 and to Compare the Safety of the Study Drug to Apixaban, a Non-vitamin K Oral Anticoagulant (NOAC) in Patients With Irregular Heartbeat (Atrial Fibrillation) That Can Lead to Heart-related Complications. [Phase 2]
Phase 2 trial evaluating proper dosing and safety of the oral FXIa inhibitor BAY 2433334 versus apixaban in patients with atrial fibrillatio…
-
CLINICAL_TRIALS trial_result · 2022-10-27Clinical Trial Update: Semaglutide to Reduce Atrial Fibrillation Burden [Phase 4]
Phase 4 clinical trial investigating semaglutide to reduce atrial fibrillation burden is currently suspended.
-
FDA approval · 2022-10-25FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for sotalol hydrochloride by Teva Pharmaceuticals USA, Inc., indicating regulatory approval of a…
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE [Phase 4]
A Phase 4 clinical trial update evaluating an anti-platelet strategy after left atrial appendage closure in atrial fibrillation patients.
-
CLINICAL_TRIALS trial_result · 2022-10-07Clinical Trial Update: IvaBRAdine blocK of Funny Current for Heart Rate Control in permanEnt Atrial Fibrillation. (BRAKE-AF Study). [Phase 3]
Phase 3 trial BRAKE-AF evaluating ivabradine block of funny current for heart rate control in permanent atrial fibrillation has completed.
-
CLINICAL_TRIALS trial_result · 2022-10-03Clinical Trial Update: Head-to-head Comparison of Single Versus Dual Antiplatelet Treatment Strategy After Percutaneous Left Atrial Appendage Closure: a Multicenter, Randomized Study [Phase 3]
A Phase 3 randomized trial comparing single versus dual antiplatelet therapy after left atrial appendage occlusion is being conducted across…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) [Phase 3]
A Phase 3 trial comparing apixaban with vitamin K antagonists in patients with atrial fibrillation and end-stage kidney disease has complete…
-
FDA approval · 2022-09-23FDA Approved: DILTIAZEM HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals, Inc)
FDA approves ScieGen's generic diltiazem hydrochloride under an Original Application (ANDA).
-
CLINICAL_TRIALS trial_result · 2022-09-16Clinical Trial Update: Left Atrium Reservoir Function Modulation in Patients With Atrial Fibrillation: Digoxin Versus Beta Blocker [Phase 3]
Phase 3 trial comparing digoxin versus beta blocker for modulation of left atrial reservoir function in atrial fibrillation.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure [Phase 2]
Phase 2 trial evaluating a genetically targeted therapy to prevent symptomatic atrial fibrillation in patients with heart failure; study com…